Metacrine: Metacrine : Termination of Material Agreement - Form 8-K
(marketscreener.com) 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 ...https://www.marketscreener.com/quote/stock/METACRINE-INC-112492611/news/Metacrine-Termination-of-Material-Agreement-Form-8-K-42947116/?utm_medium=RSS&utm_content=20230209
Read full article »
Metacrine is a California-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of gastrointestinal and liver diseases.
Read more